- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
iPLEDGE and Isotretinoin: What Happened?
Author(s):
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.
In this first part of a video interview with Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, Peebles explains the history of iPLEDGE and what may have led to the current difficulties that physicians, pharmacies, and patients are dealing with.
Video Player is loading.
Related Videos
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products
Advancing Acne Care: New Therapies and Technologies
Balancing Adolescent Acne Treatment and Well-being
Adolescent Acne Management: Strategic Approaches and Leveraging Clascoterone Cream
Comprehensive Acne Management: Exploring the Role of Combination and Food Independent Treatments in an adolescent treatment-naïve patient
Understanding Clascoterone Cream: MOA, Patient Selection Criteria, and Gender-Inclusive Advantages
Navigating Acne Management: Balancing Patient Expectations and Optimizing Skincare Regimens
Critical Insights into Isotretinoin Use: Dietary Considerations and Food-Independent Options
Related Content
